4//SEC Filing
Kuhn Mary J 4
Accession 0001225208-11-000650
CIK 0001405197other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:42 PM ET
Size
9.5 KB
Accession
0001225208-11-000650
Insider Transaction Report
Form 4
Kuhn Mary J
Executive VP, Operations
Transactions
- Exercise/Conversion
Common Stock
2011-01-03$1.39/sh+54,697$76,029→ 115,878 total - Exercise/Conversion
Options (right to buy)
2011-01-03$1.39/sh−54,697$76,029→ 334,113 totalExercise: $1.39From: 2006-04-01Exp: 2015-11-10→ Common Stock (54,697 underlying) - Sale
Common Stock
2011-01-03$23.08/sh−54,697$1,262,374→ 61,181 total
Footnotes (4)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2010.
- [F2]The number of shares reported includes restricted share units representing the right to receive 9,210 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.93 to $23.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The option is fully vested and immediately exercisable.
Documents
Issuer
Talecris Biotherapeutics Holdings Corp.
CIK 0001405197
Entity typeother
Related Parties
1- filerCIK 0001472044
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:42 PM ET
- Size
- 9.5 KB